Acreage Holdings, Inc.

The stock remains in a deep downtrend, trading well below its 200-day and 50-day moving averages. The longer-term setup is still damaged, with price far closer to the 52-week low than the 52-week high, even after a recent bounce off the lows.

Street sentiment is mildly constructive, with a Buy consensus and a $0.40 target versus a much lower trading level. There have been no recent rating changes, so the setup is driven more by valuation recovery potential than by fresh analyst momentum.

Expect a low bar but still a difficult earnings profile. The company has missed all seven reported EPS comparisons, while next-year EPS is projected to improve to -$0.03 from -$0.85, so shareholders should watch whether losses narrow and revenue stabilizes.

No discretionary insider buying or selling stands out. Recent activity is dominated by award grants and other automatic compensation-related entries for senior executives and directors, which are not a clear signal of conviction either way.

Profitability remains weak, with ROE at -135.6% and EPS TTM at -0.85. Revenue growth is still negative at -32.9% year over year, but gross margin holds at 49.5%, giving the business some operating leverage if sales stabilize.

Against specialty cannabis peers, the company looks like a distressed microcap with a sub-$5 million market value and a heavy debt load. The balance sheet is stretched with $232.8 million of debt against $13.6 million of cash, so valuation is more recovery case than quality premium.